BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 7689666)

  • 21. The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism.
    Tsai WC; Pei D; Wang TF; Wu DA; Li JC; Wei CL; Lee CH; Chen SP; Kuo SW
    Clin Endocrinol (Oxf); 2005 May; 62(5):521-4. PubMed ID: 15853819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short-term hyperthyroidism followed by transient pituitary hypothyroidism in a very low birth weight infant born to a mother with uncontrolled Graves' disease.
    Higuchi R; Kumagai T; Kobayashi M; Minami T; Koyama H; Ishii Y
    Pediatrics; 2001 Apr; 107(4):E57. PubMed ID: 11335778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Graves' disease in pregnancy: prospective evaluation of a selective invasive treatment protocol.
    Nachum Z; Rakover Y; Weiner E; Shalev E
    Am J Obstet Gynecol; 2003 Jul; 189(1):159-65. PubMed ID: 12861156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of antiepileptic drugs on hGH, TSH, and thyroid hormone concentrations during pregnancy.
    Kaneko S; Otani K; Fukushima Y; Sato T; Narita S; Kurahashi K; Ogawa Y; Nomura Y; Shinagawa S
    Int J Biol Res Pregnancy; 1982; 3(4):148-51. PubMed ID: 7152712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Central congenital hypothyroidism due to Graves' disease in the mother].
    Liebrand CA; de Mol AC; Kempers MJ; Noordam C
    Ned Tijdschr Geneeskd; 2006 Oct; 150(41):2229-32. PubMed ID: 17076354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves' hyperthyroidism.
    Momotani N; Noh JY; Ishikawa N; Ito K
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3633-6. PubMed ID: 9360518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Foetal and neonatal thyroid disorders.
    Radetti G; Zavallone A; Gentili L; Beck-Peccoz P; Bona G
    Minerva Pediatr; 2002 Oct; 54(5):383-400. PubMed ID: 12244277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of neonates born to women with Graves' disease: a cohort study.
    Besançon A; Beltrand J; Le Gac I; Luton D; Polak M
    Eur J Endocrinol; 2014 Jun; 170(6):855-62. PubMed ID: 24670885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
    He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Individual outcome monitoring of TSH receptor antibody level for predicting the prognosis of Graves' disease].
    Rink T; Holle LH; Schroth HJ; Garth H
    Nuklearmedizin; 1998 May; 37(3):90-4. PubMed ID: 9604228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of Graves' disease during pregnancy: the key role of fetal thyroid gland monitoring.
    Luton D; Le Gac I; Vuillard E; Castanet M; Guibourdenche J; Noel M; Toubert ME; Léger J; Boissinot C; Schlageter MH; Garel C; Tébeka B; Oury JF; Czernichow P; Polak M
    J Clin Endocrinol Metab; 2005 Nov; 90(11):6093-8. PubMed ID: 16118343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neonatal hypothyroxinemia with normal thyrotropin. Clue to maternal Graves' disease.
    Slyper AH; Shaker JL
    Clin Pediatr (Phila); 1993 Feb; 32(2):121-3. PubMed ID: 8094332
    [No Abstract]   [Full Text] [Related]  

  • 33. Fetal Goitrous Hyperthyroidism in a Pregnant Woman with Triiodothyronine-Predominant Graves' Disease.
    Washio K; Uenaka M; Tanimura K; Deguchi M; Nishida K; Fujioka K; Yamada H
    Kobe J Med Sci; 2021 Feb; 66(4):E153-E158. PubMed ID: 33994519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thyroid function: fetal-maternal relationship at term.
    Mungan T; Vicdan K; Yalcin H; Turhan N
    J Pak Med Assoc; 1994 May; 44(5):104-6. PubMed ID: 8078174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transplacental passage of anti-thyroid auto-antibodies in a pregnant woman with auto-immune thyroid disease.
    Radetti G; Persani L; Moroder W; Cortelazzi D; Gentili L; Beck-Peccoz P
    Prenat Diagn; 1999 May; 19(5):468-71. PubMed ID: 10360517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High iodine (substrate) turnover Graves' disease: the intriguing 'rapid responder' variant of thyrotoxicosis.
    Dalan R; Leow MK; Ng DC
    Ann Clin Biochem; 2008 Nov; 45(Pt 6):612-5. PubMed ID: 18941129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Graves' Disease during pregnancy--results of antithyroid drug therapy.
    Dwarakanath CS; Ammini AC; Kriplani A; Shah P; Paul VK
    Singapore Med J; 1999 Feb; 40(2):70-3. PubMed ID: 10414160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Thyroid functional changes of normal human fetus and newborns].
    Zhao Y; Zhang LJ; Wei YQ; Feng YJ
    Zhonghua Fu Chan Ke Za Zhi; 2003 Sep; 38(9):538-40. PubMed ID: 14680607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Congenital thyrotoxicosis in premature infants.
    Smith C; Thomsett M; Choong C; Rodda C; McIntyre HD; Cotterill AM
    Clin Endocrinol (Oxf); 2001 Mar; 54(3):371-6. PubMed ID: 11298090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum IL-18 levels are not increased in patients with untreated Graves' ophthalmopathy.
    Wakelkamp IM; Prummel MF; Wiersinga WM
    Horm Metab Res; 2004 Jan; 36(1):44-7. PubMed ID: 14983406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.